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Tuberous sclerosis complex (TSC) is a leading genetic cause of autism. The TSC proteins Tsc1 and Tsc2 control the mTORC1 signaling
pathway in diverse cells, but how the mTORC1 pathway is specifically regulated in neurons remains to be elucidated. Here, using an
interactionproteomics approach inneural cells includingneurons,weuncover the brain-enrichedprotein huntingtin-associatedprotein
1 (Hap1) as a novel functional partner of Tsc1. Knockdown of Hap1 promotes specification of supernumerary axons in primary hip-
pocampal neurons and profoundly impairs the positioning of pyramidal neurons in the mouse hippocampus in vivo. The Hap1
knockdown-induced phenotypes in primary neurons and in vivo recapitulate the phenotypes induced by Tsc1 knockdown.We also find
that Hap1 knockdown in hippocampal neurons induces the downregulation of Tsc1 and stimulates the activity of mTORC1, as reflected
by phosphorylation of the ribosomal protein S6. Inhibition of mTORC1 activity suppresses the Hap1 knockdown-induced polarity
phenotype in hippocampal neurons. Collectively, these findings define a novel link between Hap1 and Tsc1 that regulates neuronal
mTORC1 signaling and neuronal morphogenesis, with implications for our understanding of developmental disorders of cognition.
Introduction
Tuberous sclerosis complex (TSC) is a developmental disorder
and leading genetic cause of autism. Neurological manifestations
of TSC include epilepsy, autistic disorder, intellectual disability
(ID), learning disabilities, and behavioral disturbances (Orlova
andCrino, 2010). Because our understanding of the pathogenesis
of TSC is poor, treatment options for patients with these disor-
ders remain inadequate.
Mutations of the TSC1 or TSC2 genes cause TSC (Orlova and
Crino, 2010). The TSC1 and TSC2 proteins centrally regulate the
mTORC1 signaling pathway. The TSC1-TSC2 dimer inhibits the
mTORC1 activator, Rheb. Loss of TSC1-TSC2 function activates
the mTORC1 pathway, which normally drives protein synthesis
in response to diverse signals (Ma and Blenis, 2009). Deregulated
protein synthesis stemming from perturbation of the mTORC1
pathway is associated with seizures and learning and behavior
deficits in animals, and mutations in TSC1, TSC2, PTEN, eIF4E,
and FMRP in autism and ID suggest that deregulation of the
mTORC1 pathway plays a role in the pathogenesis of these brain
disorders (Santini et al., 2013). However, how the mTORC1
pathway is specifically regulated in neurons remains largely
unexplored.
The advent of computation-assisted interaction proteomics led
us to systematically search for binding partners of autism spectrum
disorder (ASD)- and ID-linked proteins. Usingmultiple parallel af-
finity purifications and the CompPASS analysis platform (Sowa et
al., 2009), we applied an immunoprecipitation-mass spectrometry
(IP-MS) approach inneurons.Here,we identify theproteinHap1as
anovelbindingpartnerofTsc1.Hap1, a67kDaor70kDaprotein (A
or B rodent isoforms, respectively), was originally identified as an
interactor of the protein Huntingtin (Li et al., 1995). Hap1 may
regulate the trafficking of microtubule- and membrane-associated
protein cargoes in neurons. In this function, Hap1 is thought to
promoteproteinrecyclingandpreventproteindegradation(Ronget
al., 2007; Sheng et al., 2008). Interestingly, Hap1 expression appears
to be largely limited to neural tissues (Dragatsis et al., 2000). We
found that Hap1 knockdown promotes the specification of super-
numerary axons in hippocampal neurons, andHap1 knockdown in
the developing hippocampus impairs the positioning of pyramidal
neurons in vivo, mimicking the effect of Tsc1 knockdown. In bio-
chemical assays, Hap1 knockdown triggers the downregulation of
endogenous neuronal Tsc1 and stimulates phosphorylation of the
mTORC1-regulated ribosomal protein S6. In epistasis analyses, in-
hibition of mTORC1 by rapamycin or an active form of Tsc2 sup-
presses the Hap1 knockdown-induced phenotype in neurons.
Together, these data identify a novel function for Hap1 in the regu-
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Figure 1. Identification of Hap1 as a novel Tsc1-interacting protein. A, IP-MS-CompPASS of Tsc1 in neuro2a and cortical neurons. Lysates of stable FLAG-Tsc1-expressing neuro2a or FLAG-Tsc1
lentivirus-infected cortical neuronswere FLAG resin-immunoprecipitated. Bait complexeswere analyzed by LCMS/MS. Analysiswas done in CompPASS against dedicated neuro2a or cortical neuron
IP-MS databases. High-confidence interacting proteins had normalized weighted D (NWD) scores1. Total appearances across unrelated parallel IP-MS bait-runs are shown (“Ratio”). “Spectral
counts” represent the number of tryptic peptides detected by the mass spectrometer corresponding to each protein. B, Reciprocal coimmunoprecipitations of Hap1 and (Figure legend continues.)
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lation of neuronal mTORC1 signaling and consequent neuronal
morphogenesis.
Materials andMethods
All animal work was approved by the Harvard Institutional Animal Care
and Use Committee.
Immunoprecipitation-mass spectrometry (IP-LC-MS/MS). IP-MS was
performed as described (Sowa et al., 2009), with modifications. Mouse
neuro2a cells or rat DIV5 primary cortical neurons were infected with
lentiviruses encoding individual FLAG-tagged baits. The neuronal syn-
apsin1 promoter (Syn-pHAGE-N-FLAG vector) was used in cortical
neurons. Puromycin resistance selected for stable expression in neuro2a.
Lysates of neuro2a or DIV10 cortical neurons were subjected to immu-
noprecipitation using FLAG resin (Sigma), followed by 3XFLAG peptide
elution (Sigma) and TCA precipitation. Proteins were trypsinized
(Sequencing-Grade Trypsin, Promega) and washed (3M Empore C18
media), and tryptic peptides were loaded onto an LTQ linear ion trap
mass spectrometer (ThermoFinnigan). Spectra were searched against
target-decoymouse or rat tryptic peptide databases. CompPASS analysis
was done against dedicated neuro2a (60 bait-runs) or cortical neuron
(40 bait-runs) IP-MS databases.
Plasmids.ORFs for IP-MS were subcloned by Gateway recombination
into pHAGE-N-FLAG lentiviral vector. pRK7-FLAG-human TSC1 and
TSC2 were from J. Blenis; pcdna3-FLAG-TSC2 Ser939Ala/Thr1462Ala
was from Addgene. Rat Hap1 was amplified from P6 rat brain cDNA.
shRNAs were expressed from pBluescript-U6 or subcloned into pLen-
tiLox 3.7 for lentivirus. Rat shRNAs are as follows: Hap1i.1, GCTGCA-
GAGAGGAACGAAAGA; Hap1i.2, CACCGAAGATGATATCAAAGT;
Hap1i.3, AGCTGAAACTGCTGGAAGAAG; Hap1i.4, GCTCCTACAT-
GCAGGATTATG; Tsc1i.1, CTAAAGAGCTTTCTGAGATCA. Mouse
shRNAs are as follows: scrambled control, TACGCGCATAAGATTAGGGTA;
Hap1i.1, GAAGAAGATCACCGAAGATGA; Hap1i.2, CACCGAAGAT-
GATATCAAAGT;Tsc1i3,GATTATTACCTGGAAACCAAT.
Antibodies. Tsc1 (#4906), Tsc2 (D93F12, #4308), phosphoS6 235/236
(D57.2.2E, #4858), total S6 (5G10, #2217), and Erk (#9102) antibodies
were from Cell Signaling Technologies. Hap1 antibody (#611302) was
from BD Biosciences. Tau1 antibody (PC1C6, #MAB3420) was from
Millipore. The GFP antibody was produced in rabbit using recombinant
GFP. The tubulin antibody (neuronal -III, TUJ1, #MMS-435P) was
from Covance.
Coimmunoprecipitation analyses in HEK293T cells. Coimmunopre-
cipitations were performed as described (Litterman et al., 2011). Lysates
were prepared in 1% Triton-X, 0.05% SDS, 0.025% deoxycholate, 150
mM NaCl, 50 mM Tris-HCl, 2 mM EDTA.
Hippocampal culture, transfection, lentiviral infection. Hippocampal
cultures and transfections were done 2 h after plating as described (de la
Torre-Ubieta et al., 2010). For biochemistry, neurons were plated at
1.0  106 cells/well, and lentiviral infection was performed 2 h after
plating. Lysates were prepared in 1% Triton-X, 0.1% SDS, 0.05 deoxy-
cholate, 150 mM NaCl, 50 mM Tris-HCl, 2 mM EDTA.
Hippocampal in utero electroporation. Electroporation of hippocampal
germinal zone was performed as described (Navarro-Quiroga et al.,
2007). E15 embryos of either sex were injected into the lateral ventricle (2
g/L RNAi plasmid, 0.5 g/L pCAG-Venus-IRES-GFP) and electro-
porated along an ear-to-ear axis and slight rostrocaudal axis (6 pulses, 35
V for 50ms, 950ms intervals). Pups developed until P3. Brainswere fixed
in 4% sucrose/4% formaldehyde, and cryoprotected in 30% sucrose; 40
m coronal cryosections were prepared.
Immunostaining. Immunostaining was performed as described (de la
Torre-Ubieta et al., 2010).
Statistical analyses. Statistics were performed inGraphPadPrism. Pair-
wise comparisons within multiple groups were done by two-way
ANOVA followed by Bonferroni post hoc test. Percentage data in histo-
grams are presented as mean SEM.
Results
Identification of Hap1 as a novel Tsc1 interactor
To identify novel Tsc1 signaling mechanisms in neurons, we ap-
plied an IP-MS-based interaction proteomics approach in neural
cells using CompPASS (Sowa et al., 2009). We expressed FLAG-
tagged Tsc1 in mouse neuro2a cells or primary rat cortical neu-
rons. Lysates were subjected to immunoprecipitation using
FLAG resin, and eluted trypsinized bait complexes were sub-
jected to LC-MS/MS. The resulting protein assignments were
analyzed in CompPASS, wherein we compared the set of proteins
that copurified with Tsc1 against a large number of parallel
IP-MS datasets generated in mouse neuro2a or primary rat cor-
tical neurons. These analyses led to the identification of high-
confidence interacting proteins distinct from background.
We found that Tsc1 copurified the proteins Tsc2 and Tbc1d7
as high-confidence interactors (Fig. 1A), which are known inter-
actors of Tsc1 (Dibble et al., 2012), validating our IP-MS
approach. We also uncovered the protein Hap1 as a novel high-
confidence interactor of Tsc1 in both neuro2a cells and primary
neurons (Fig. 1A). The expression of Hap1 is enriched in the
brain and largely limited to nervous system cells (Dragatsis et al.,
2000), suggesting that Hap1 may represent a neural cell-specific
partner of Tsc1.
We validated the Hap1–Tsc1 interaction. Exogenous Hap1
and Tsc1 coimmunoprecipitated in a reciprocal fashion in cells
(Fig. 1B). Exogenous Hap1 also promoted the abundance of the
coexpressed Tsc1 protein (Fig. 1B). Importantly, endogenous
Hap1 and endogenous Tsc1 formed a complex in neuro2a cells
and in mouse brain (Fig. 1C). Notably, a proportion, but not all,
of endogenous Hap1 interacted with endogenous Tsc1. In other
analyses,Hap1 also copurified the Tsc1 partner protein Tsc2 (Fig.
1B,C), suggesting thatHap1 forms a complexwith the Tsc1-Tsc2
dimer.
We mapped the domains that mediate the interaction of Tsc1
and Hap1. Deletion of the entire N-terminal region upstream of
the Tsc1 coiled-coil domain (1–721), the Tsc2-binding region
(302–430) (Hodges et al., 2001), or the C-terminal 167 amino
acids (997–1164) of Tsc1 had little or no effect on the interaction
withHap1 (Fig. 1D; and data not shown). By contrast, deletion of
the Tsc1 coiled-coil domain (721–997) reduced the interaction of
Tsc1 with Hap1 (Fig. 1D). In analyses of Hap1, the Hap1 coiled-
coil domain 3 (CC3; 354–417) was sufficient to interact with
Tsc1. In contrast, coiled-coil domains 1 and 2 (CC1,2; 254–354)
failed to associate with Tsc1 (Fig. 1E). Together, these data sug-
gest that Hap1 and Tsc1 interact in cells and in the brain, and that
the interaction occurs through coiled-coiled domains.
4
(Figure legend continued.) Tsc1. First and second panels from left, Lysates of HEK293T trans-
fected with FLAG-Tsc1 and Myc-Hap1B were subjected to immunoprecipitation followed by
immunoblotting. Myc-Hap1 interactedwith FLAG-Tsc1 and increased FLAG-Tsc1 protein abun-
dance. Third panel from left, Lysates of HEK293T transfected with FLAG-Tsc2 and Myc-Hap1B
were subjected to immunoprecipitation followed by immunoblotting. Right, Lysates of
HEK293T transfectedwith FLAG-Tsc1, HA-Tsc2, andMyc-Hap1Bwere subjected to immunopre-
cipitation and immunoblotting. HA-Tsc2was coexpressed to obtain equal levels of Tsc1 because
Hap1 expression increases Tsc1 protein abundance. C, Endogenous coimmunoprecipitation of
Hap1 and Tsc1. Lysates of E18mouse brain or neuro2a were subjected to immunoprecipitation
followed by immunoblotting. D, Tsc1 deletion mutant coimmunoprecipitation analyses. Ly-
sates of HEK293T transfectedwith FLAG-Tsc1 deletionmutants andMyc-Hap1Bwere subjected
to immunoprecipitation using FLAG antibody, followed by immunoblotting using Myc anti-
body. Deletion of Tsc1 coiled-coil domain (CC) but not Tsc2-binding domain (TSC2BD), Tsc1
N terminus (Nterm), or the C-terminal 167 amino acids (data not shown), reduced the inter-
action with Hap1, suggesting that interaction is mediated through Tsc1 coiled-coil domain. E,
Hap1 coimmunoprecipitation analyses. Lysates of HEK293T transfected with Myc-Hap1B
coiled-coil (CC) fragments and FLAG-Tsc1 were subjected to immunoprecipitation using Myc
antibody followed by immunoblotting using FLAG antibody. Hap1 coiled-coil domain 3 (CC3
alone) was sufficient to interact with Tsc1.
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Hap1 regulates axon specification and positioning of
hippocampal pyramidal neurons
Having identified Hap1 as a Tsc1 interactor, we asked whether
these proteins shared biological roles in neurons. Both Tsc1
and Hap1 were expressed in hippocampal neurons (Fig. 2A).
Their levels increased from DIV0 to DIV5 (Fig. 2A), which
coincides temporally with the specification and outgrowth of
axons. To probe for a role of Hap1 in axon development, we
Figure 2. Hap1 and Tsc1 regulate hippocampal pyramidal neuron axon specification and positioning.A, Lysates of hippocampal neurons from0 to 5DIVwere subjected to immunoblotting using
the Tsc1, Hap1, or Tubulin (-III type) antibody. B, E18 rat hippocampal neurons transfected 2 h after plating with the control U6 RNAi or Hap1 RNAi or Tsc1 RNAi plasmids were subjected to
immunocytochemistry on DIV5 using the GFP (green) and the axonal antigen Tau1 (red) antibodies. Scale bar, 20m. The i.1, i.2, i.4 nomenclature refers to individual shRNAs. C, Quantification of
axon specification as percentage of neurons. Hap1or Tsc1 knockdownpromoted specification of supernumerary axons (n3 experiments). ***p0.001 (two-wayANOVAandpost hocBonferroni
test). No axon spec., neurons that failed to specify a Tau1-immunoreactive axon.D, Lysates of HEK293T cells transfectedwithMyc-Hap1 and control U6 RNAi or Hap1 RNAi (top) or DIV5 hippocampal
neurons infected 2 h after platingwithU6RNAi or Tsc1 RNAi (bottom)were subjected to immunoblotting. E, E15micewere electroporatedwithHap1RNAi, Tsc1 RNAi, or scrambled control RNAi and
VENUS-IRES-EGFP plasmids. Brains were harvested on P3 and subjected to immunohistochemistry using the GFP (green) antibody and Hoechst 33258 (purple). Scale bar, 50 m. SP, Stratum
pyramidale; SO, stratum oriens. F, Quantification of neuronal position as percentage of neurons. Knockdown of Tsc1 or Hap1 impaired neuronal positioning into the SP in the hippocampus in vivo
(n3). ***p0.001 (two-wayANOVAandpost hocBonferroni test). Numberof animals analyzedper condition is shown.G, Lysates ofmouseneuro2a cells transfected for 3dwith controlU6RNAi,
Hap1 RNAi, or Tsc1 RNAi were subjected to immunoblotting.
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used a plasmid-based method of RNAi (Gaudilliere et al.,
2002). Knockdown of Hap1 in hippocampal neurons pro-
moted the specification of more than one axon per neuron
(Fig. 2B,C). The Hap1 knockdown-induced phenotype reca-
pitulated the effect of Tsc1 knockdown, which led to the spec-
ification of supernumerary axons (Fig. 2B,C) (Choi et al.,
2008). These data suggest that Hap1 and Tsc1 suppress axon
specification in hippocampal neurons.
We determined the role of Hap1 in hippocampal neuron de-
velopment in vivo. Because the establishment of axon-dendrite
polarity is critical for proper migration and positioning of devel-
oping pyramidal neurons (Barnes and Polleux, 2009; de la Torre-
Ubieta and Bonni, 2011), we reasoned that Hap1 and Tsc1 might
influence neuronal positioning in the hippocampus in vivo.
Using in utero electroporation in embryonic day 15 (E15)
mice, we found that pyramidal neurons in control mice at
postnatal day 3 (P3) completedmigration through the stratum
oriens and incorporated into the pyramidal cell layer (Fig.
2E,F ). In contrast, pyramidal neurons in Hap1 knockdown
animals failed to reach the pyramidal cell layer, and their soma
remained within the stratum oriens (Fig. 2E,F ). Notably, Tsc1
knockdown phenocopied the impairment of pyramidal neu-
ron positioning in the hippocampus induced by Hap1 knock-
down (Fig. 2E,F ). Collectively, our data suggest that both
Hap1 and Tsc1 regulate axon-dendrite morphogenesis and
positioning of hippocampal pyramidal neurons.
Hap1 regulates Tsc1 abundance and
mTORC1 signaling in neurons
We next determined a mechanism by
which Hap1 might regulate Tsc1 function
in cells. Tsc1 protein is not expressed at a
high level in cells in the absence of coex-
pressed Tsc2 resulting from low solubility
and stability (Nellist et al., 1999).Expression
of Hap1 strongly promoted the abundance
of coexpressedTsc1,mimicking the effect of
Tsc2 coexpression (Figs. 1B and 3A). Im-
portantly, lentivirus-mediated knockdown
of Hap1 triggered downregulation of en-
dogenous Tsc1 in hippocampal neurons
(Fig. 3B). The extent of Tsc1 downregula-
tion correlated with the extent of Hap1
knockdown (Fig. 3B). Because Tsc1-Tsc2 is
an essential negative regulator of mTORC1
signaling, we assessed the role of Hap1 in
regulating the mTORC1 pathway in
neurons. Knockdown of Hap1 in hip-
pocampal neurons stimulated phosphory-
lation of the mTORC1 effector protein S6
(Fig. 3C). Together, these data suggest that
Hap1 promotes the abundance of Tsc1 and
inhibits neuronal mTORC1 signaling.
We next assessed the role of mTORC1
signaling on Hap1-mediated control of
hippocampal neuron development. Inhibi-
tion of mTORC1 by rapamycin suppressed
the specification of supernumerary axons
induced by Hap1 knockdown and re-
stored single-axon polarity in these neu-
rons (Fig. 4A,B). Rapamycin had little or
no effect on single axon specification in
control neurons (Fig. 4B), suggesting a
specific suppression of the Hap1 knock-
down effect. In complementary experiments, inhibition of
mTORC1 by expression of an active form of Tsc2, in which
inhibitory Akt phosphorylation sites (Ser939/Thr1462) were re-
placed with alanine (Tsc2SA/TA) (Manning et al., 2002), sup-
pressed the specification of supernumerary axons and restored
single-axon polarity in Hap1 knockdown neurons (Fig. 4C,D).
Together, these data suggest that Hap1 regulates neuronal mor-
phogenesis upstream of neuronal mTORC1, by promoting Tsc1
function and inhibiting mTORC1 signaling.
Discussion
In this study, we have identified a novel Hap1–Tsc1 signaling
link that controls the mTORC1 pathway in neurons. Accord-
ingly, depletion of Hap1 promotes specification of supernumer-
ary axons in hippocampal neurons and profoundly impairing
the positioning of hippocampal pyramidal neurons in vivo.
We have also elucidated amechanism by which Hap1 regulates
neuronal Tsc1 function. Hap1 knockdown triggers the down-
regulation of Tsc1 and activates the mTORC1 signaling pathway in
hippocampal neurons. Consistent with these findings, inhibi-
tion of mTORC1 signaling suppresses the Hap1 knockdown-
induced axon phenotype in neurons. Our findings uncover
Hap1 as a novel regulator of neuronal Tsc1-Tsc2/mTORC1
signaling and define a critical role for the Hap1–Tsc1 interac-
tion in the control of axon development and neuronal posi-
tioning in the brain.
Figure 3. Hap1 controls Tsc1 abundance and S6 phosphorylation.A, Lysates of HEK293T cells transfectedwith FLAG-Tsc1 alone
or FLAG-Tsc1 together with FLAG-Tsc2 or Myc-Hap1B were subjected to immunoblotting. Coexpression of Myc-Hap1B or FLAG-
Tsc2 promoted FLAG-Tsc1 abundance. Arrow indicates location of Tsc1. B, Lysates of DIV5 hippocampal neurons infected on DIV0
2 h after plating with Hap1 RNAi or control lentivirus cultured under basal conditions were subjected to immunoblotting. Hap1
knockdown triggered downregulation of Tsc1 and Tsc2. The i.1, i.3 nomenclature refers to individual shRNAs. C, Lysates of DIV5
hippocampal neurons infected on DIV0 2 h after plating with RNAi cultured under basal conditions were subjected to immuno-
blotting. Hap1 knockdown triggered downregulation of Tsc1 and Tsc2 and stimulated phosphorylation of themTORC1 effector S6.
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Hap1 represents, to our knowledge,
the first identified neural-specific molec-
ular regulator of mTORC1 signaling. This
finding suggests the interesting possibility
that disruption of neuron-specific regula-
tors of mTORC1 signaling might contrib-
ute to the pathogenesis of neurological
manifestations of TSC, including autism,
intellectual disability, and epilepsy.
The identification of Hap1 as a novel
interactor of Tsc1 should shed light on the
regulation of the neuronal Tsc1-Tsc2
complex. Tsc1 and Tsc2 depend on each
other for their solubility and stability, and
loss of either protein or dissociation of the
Tsc1-Tsc2 dimer impairs mTORC1 sig-
naling (Orlova and Crino, 2010; Dibble et
al., 2012). Studies in non-neural cells sug-
gest that the Tsc1-Tsc2 complex also con-
tains the protein Tbc1d7 (Nakashima et
al., 2007; Dibble et al., 2012). Our IP-MS
analyses revealed that Tbc1d7 also inter-
acts with Tsc1 in neurons, suggesting that
the Tsc1-Tbc1d7-Tsc2 complexmay form
in neurons. It will be interesting to deter-
mine whether Hap1might cooperate with
Tbc1d7 or Tsc2 to regulate the abundance
of Tsc1 in neurons and thereby regulate
neuronal mTORC1 signaling.
Tsc1-Tsc2 and mTORC1 pathway
components control axon development
and pyramidal neuron morphogenesis
(Han and Sahin, 2011). Loss of Tsc1-Tsc2
leads to abnormal axon development and
neuronal polarization and positioning, along
with dendritic arbor defects in the cerebral
cortex (Choi et al., 2008; Li et al., 2008; Feli-
cianoet al., 2011;Gotoet al., 2011).Our study
suggests Hap1 regulates pyramidal neuron
axon specification and positioning and
strengthens the link between axon-dendrite
polarization andneuronpositioning.
The identification of an intimate Hap1–
Tsc1 connection bears implications for both
Hap1 and mTORC1 signaling beyond the
control of axonmorphogenesis and neuronal
positioning. It will be interesting to determine the role of Hap1 in
the control of long-termdepression and hippocampal excitatory/
inhibitory balance, which are regulated by Tsc1 (Bateup et al.,
2013). Conversely, it will be interesting to investigate whether
Tsc1 may influence Hap1 functions, including regulation of
GABAA receptor surface expression (Rong et al., 2007).
Our study demonstrates that multibait IP-MS interaction
proteomics approaches can be performed in primary neurons.
Prior similar efforts on Tsc1 and other proteins implicated in
autism have used non-neural cells (Guo et al., 2010; Sakai et al.,
2011). Using CompPASS, we have identified high-confidence in-
teractions in endogenous neural proteomes. It will be interesting
to apply similar IP-MS approaches to human neuronal pro-
teomes, including in patient-derived neurons.
Loss of TSC1 protein function in the brain in TSCmanifests as
autism, epilepsy, and ID. Our study reveals that Hap1 controls
Tsc1 function in neurons, raising the possibility that Hap1 may
play a role in the control of cognitive and neurological function.
Remarkably, recent whole-exome sequencing has identified a
rare complete Hap1 knock-out among patients with ASD (Lim et
al., 2013), suggesting that Hap1 may be relevant to ASD patho-
genesis. Elucidation of a Hap1-TSC1 signaling link in ASD may
expand our understanding of the molecular components at play
in ASD pathogenesis.
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